Neuroverse's C.E.O., Dr. Gil-da-Costa holds B.S. and M.S. degrees in Biology, and a Ph.D. in Cognitive Neurosciences - Biomedical Sciences. For the last 19 years, his pursuit of how the mind and brain work led him to behavioral field studies in Africa and Central America and neurophysiology laboratory research from Harvard University to the National Institutes of Health, where for 5 years he held a double affiliation at the National Institute of Mental Health and the National Institute on Deafness and Other Communication Disorders. His research has been distinguished with multiple awards, such as the Donald B. Lindsley Prize for Behavioral Neuroscience, featured in Nature Neuroscience and selected for the Society for Neuroscience 2012 Hot Topics List. Altogether, his research has contributed seminal findings on the evolutionary and neural foundations of human cognition and language, which are now incorporated in neurosciences reference textbooks and university curriculae. In the last 10 years, Dr. Gil-da-Costa's work has focused on translational research, developing novel brain imaging methods and brain-machine interfaces. First at the Salk Institute for Biological Studies, where these endeavors led to the development of several US patents and to co-founding Neuroverse. Dr. Gil-da-Costa is a reviewer for a wide variety of scientific journals and a science advisor for the Science and Entertainment Exchange, a program of the National Academy of Sciences, and for the National Academies Keck Future Initiatives, participating in the authorship of the interdisciplinary research team report on brain-computer interfaces, integrated in the volume "The Informed Brain in a Digital World".

Our team combined expertise in neurophysiology, cognitive psychology, mental health, neuroergonomics, advanced analytical methods & bio and electrical engineering has enabled Neuroverse to develop a unique brain interface capable of serious neurocognitive assessments and neurofeedback, in a wearable intuitive form factor.

This multidisciplinary technical expertise paired with passionate and disciplined product development and financial execution led to the creation of an exciting and ever-growing system for mental health and neurocognitive applications.

 C.E.O.  Harvard University Nat. Institutes of Health Salk Institute   
Ricardo GIL-DA-COSTA, Ph.D.
Harvard University
National Institutes of Health
Salk Institute for Biological Studies
 Neuroergonomics Lead  UCSD Old Dominion University NASA Langley
Marla ZINNI, Ph.D.
Neuroergonomics Lead
U.C. San Diego
Old Dominion University
NASA Langley
 Advanced Analytics Lead  UCSD
Advanced Analytics Lead
U.C. San Diego
 Engineering Lead  UCSD Northwestern University Kettering University
Michael BAJEMA, M.Sci.
Engineering Lead
Northwestern University
Kettering University
 Operations Lead  Harvard University Nat. Institutes of Health Salk Institute
Marco LOPES, M.Sci.
Operations Lead
Harvard University
National Institutes of Health
Salk Institute for Biological Studies
 Office & Lab Manager  UCSD
Melissa CASWELL, B.Sci.
Office & Lab Manager
U.C. San Diego

Advisory Board


Shu ChieN

Dr. Chien is a leading pioneer in the field of Bioengineering. Founding chair of the UCSD Dept. of Bioengineering and the founding Director of the UCSD Institute of Engineering and Medicine. Recipient of the National Medal of Science and Member of the National Academy of Engineering, National Academy of Sciences and Institute of Medicine, and the American Academy of Arts and Sciences.


Jean-Pierre Changeux

Dr. Changeux is the Director of the laboratory of Molecular Neurobiology at the Institut Pasteur in Paris. He has contributed landmark discoveries on the molecular and cellular mechanisms of signal recognition and transduction, and is a member of the Académie des Sciences, Paris, the US National Academy of Sciences and Institute of Medicine, the American Academy of Arts and Sciences and the Royal Academy of Sciences of Sweden.


Isabel Pavão-Martins

Dr. Pavão-Martins is the Director of the Language Research Laboratory at Faculty of Medicine, University of Lisbon. She has over 20 years of both clinical and research experience on the fields of neural processing of language and migraine, with scientific publications on both subjects, and held previous positions at the National Hospital for Nervous Diseases, London, UK, and at the Dept. Neurology, The Hospitals for Sick Children, London, UK.


Gregory Light

Dr. Light is an Assistant Professor in the UCSD Department of Psychiatry, the Associate Director of the UCSD Schizophrenia Research Program, and of the Clinical Neuroscience Unit of the VISN-22 Mental Illness Research, Education, and Clinical Center (MIRECC). Dr. Light is a Clinical Psychologist with a specialization in Neuropsychology. His work has been seminal in the use of biological markers in neuropsychiatric disorders.


Gari Cheever

Mr. Cheever is a founding partner of Gunderson Dettmer's San Diego and Los Angeles offices. He has extensive experience developing, managing, and representing emerging growth companies, public corporations, venture capital and private equity firms. He spent two decades in Silicon Valley, where he represented numerous technology companies-from start-ups to Fortune 100 enterprises, including Cisco Systems, from its early days, through venture financing and IPO.

 Julia Brown

Julia Brown

Julia R. Brown, an executive from the life science industry, is a member of the Board of Directors of Targacept, Inc., Labopharm, Inc., and MediQuest Therapeutics, Inc. and of the National Association of Corporate Directors. From 2000-2003 was Executive Vice President of Amylin Pharmaceuticals, Inc. and served as Advisor to the CEO until 2008. She is a member of the board of CONNECT, from which she received the award for "Distinguished Contribution to the Life Science Industry".